NCT01596959

Brief Summary

This study will be a single blind prospective randomised control trial in patients undergoing ablation for the treatment of typical atrial flutter, with the aim of investigating the benefit of a new impedance-based computer software application which measures tissue contact between the ablation catheter and the inside of the heart. The investigators hope to demonstrate that the use of this tissue contact information reduces ablation time, Xray time, and procedure time required to complete the procedure successfully. Study participants will be randomly assigned to undergo their procedure with or without this contact data displayed for the doctor performing the ablation to see. The acute procedural endpoint of ablation is successful conduction block across the cavotricuspid isthmus of the right atrium. If the outcome of this study is positive, it will have a significant beneficial impact on this procedure, reducing procedure length, patient discomfort, and potentially reducing risk for the patient, recurrent arrythmia symptoms, and the need for repeat procedures later on.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 11, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

October 13, 2017

Status Verified

May 1, 2012

Enrollment Period

1.2 years

First QC Date

May 9, 2012

Last Update Submit

October 11, 2017

Conditions

Keywords

atrial flutterablationirrigationcontactECI

Outcome Measures

Primary Outcomes (1)

  • The primary outcome measure is the mean ablation time required to achieve the acute procedural endpoint of cavotricuspid isthmus conduction block

    immediate (intra-procedural)

Study Arms (2)

ECI CONTACT-ACTIVE

ACTIVE COMPARATOR

Irrigated Radiofrequency ablation performed using the ECI contact data

Procedure: Radiofrequency ablation utilising the ECI contact software

ECI CONTACT-INACTIVE

PLACEBO COMPARATOR

irrigated RF ablation performed to the right atrium without the use of ECI contact data

Procedure: Radiofrequency ablation without the use of ECI contact data

Interventions

irrigated radiofrequency ablation to the right atrium using the ECI contact data

Also known as: Ensite Contact, Electrical Coupling Index
ECI CONTACT-ACTIVE

irrigated RF ablation without the use of ECI contact data

ECI CONTACT-INACTIVE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is undergoing de novo cavotricuspid isthmus ablation.
  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or over

You may not qualify if:

  • (1) Previous percutaneous or open surgical procedure involving the right atrium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

John Radcliffe Hospital

Headington, Oxfordshire, OX39DU, United Kingdom

Location

MeSH Terms

Conditions

Atrial Flutter

Interventions

Radiofrequency Ablation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Radiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Timothy Betts, MbChB, MD

    Oxford University Hospitals NHS Trust

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2012

First Posted

May 11, 2012

Study Start

January 1, 2012

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

October 13, 2017

Record last verified: 2012-05

Locations